19 November 2018
Visiongain has launched a new pharma report:Laboratory Information Systems Market Report: Web-Based, On-Premise Based, Cloud-Based, Software, Hardware, Services, Clinical, Drug Discovery, Industrial.
The laboratory information system ("LIS") industry includes set of programs and hardware, which are part of an integrated system designed for healthcare information. It is an information system intended for capturing complex data and information related to medical and industrial laboratories, including clinical and analytical laboratories. The information system interfaces with analytical instruments and allows users to obtain, store, manage, retrieve and record laboratory data. As industrial and medical laboratories are diverse with different requirements; hence, there is no standard information system designed for laboratories. Therefore, a laboratory information system is customized, developed, and configured according to the requirements of a laboratory.
The lead analyst of the report commented "The global LIS market is currently fragmented in most countries, but few large vendors hold significant market shares. However, many new players are entering the market and the consolidation of small players with larger counterparts is shaping the vendor landscape. Competition is getting intense and key players are trying to sustain themselves by improving their delivery models with increased usage of technology."
Leading companies featured in the report include Abbott Laboratories, Cerner Corporation, Eclipsys Corporation, LabVantage Solutions, Inc., LabWare, Inc., McKesson Corporation, Medical Information Technology, Inc., Thermo Fisher Scientific
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.
19 October 2020
The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.
12 October 2020
We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
02 October 2020
The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.